Cancer Diagnostics companies

Bioluminescence Ventures is a biotechnology venture firm investing in Drug Discovery Platforms (Oncology, Immunology, Neuroscience, Genetic Diseases), Applied B…

4BIO’s objective is to invest in, support, and grow early stage companies developing treatments in areas of high unmet medical need, with the ultimate goal of e…

Our strategy leverages an extensive hospital system and health plan network of relationships to target attractive market segments, to identify and evaluate inve…

We are an investment firm with more than 25 years of experience backing transformational healthcare and biotech companies. We see the world through an entrepren…

This company hasn’t shared a description yet.

The myeloma patient community has no time for business as usual. Multiple myeloma is a highly heterogenous bone marrow cancer that requires a multitude of drugs…

As a Venture Capital Management firm founded in 2008, we've honed our expertise in Health Technologies: biotech, medical devices and digital health. Founded in…

Our name, Sanara, resonates the Latin word Sanare, which means ‘To Heal and To Cure’, and ‘To Improve, Put-Right and Settle’. Sanare, for us, is an harmonious a…

As part of our investment approach, we developed a structured evaluation process, the “FemHealth Framework.” The first element (re)imagines women’s health as co…

Cambrian Biopharma, a multi-asset longevity biotech, is building the medicines that will redefine healthcare in the 21st century – therapeutics to lengthen heal…

Founded in 1999, Dexcom, Inc. (NASDAQ: DXCM), develops and markets Continuous Glucose Monitoring (CGM) systems for ambulatory use by people with diabetes and by…

This company hasn’t shared a description yet.